Latest Insider Transactions at Regeneron Pharmaceuticals, Inc. (REGN)
This section provides a real-time view of insider transactions for Regeneron Pharmaceuticals, Inc. (REGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REGENERON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REGENERON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2023
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,381
-23.23%
|
$5,462,136
$856.71 P/Share
|
|
Dec 12
2023
|
Christopher R. Fenimore VP Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
2,552
-11.98%
|
$2,184,512
$856.71 P/Share
|
|
Dec 11
2023
|
Leonard S Schleifer President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,841
-3.32%
|
$10,837,804
$844.09 P/Share
|
|
Dec 11
2023
|
Leonard S Schleifer President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,155
+6.1%
|
-
|
|
Dec 11
2023
|
George Yancopoulos President and Chief Scientific |
SELL
Payment of exercise price or tax liability
|
Direct |
12,841
-1.68%
|
$10,837,804
$844.09 P/Share
|
|
Dec 11
2023
|
George Yancopoulos President and Chief Scientific |
BUY
Exercise of conversion of derivative security
|
Direct |
25,155
+3.18%
|
-
|
|
Dec 11
2023
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
5,774
-4.73%
|
$4,873,256
$844.09 P/Share
|
|
Dec 11
2023
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
725
-1.37%
|
$611,900
$844.09 P/Share
|
|
Dec 11
2023
|
Daniel P Van Plew EVP & General Mgr Industrial O |
SELL
Payment of exercise price or tax liability
|
Direct |
3,221
-7.0%
|
$2,718,524
$844.09 P/Share
|
|
Dec 11
2023
|
Christopher R. Fenimore VP Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
1,536
-3.4%
|
$1,296,384
$844.09 P/Share
|
|
Dec 11
2023
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,221
-5.34%
|
$2,718,524
$844.09 P/Share
|
|
Dec 11
2023
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
669
-2.18%
|
$564,636
$844.09 P/Share
|
|
Dec 11
2023
|
Marion Mc Court EVP Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
373
-1.79%
|
$314,812
$844.09 P/Share
|
|
Dec 11
2023
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
270
-1.28%
|
$226,260
$838.44 P/Share
|
|
Dec 08
2023
|
Andrew J Murphy EVP Research |
BUY
Grant, award, or other acquisition
|
Direct |
3,199
+4.93%
|
-
|
|
Dec 08
2023
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
883
-1.49%
|
$744,369
$843.79 P/Share
|
|
Dec 08
2023
|
Neil Stahl EVP Research and Development |
BUY
Grant, award, or other acquisition
|
Direct |
853
+1.59%
|
-
|
|
Dec 08
2023
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
809
-1.54%
|
$681,987
$843.79 P/Share
|
|
Dec 08
2023
|
Daniel P Van Plew EVP & General Mgr Industrial O |
BUY
Grant, award, or other acquisition
|
Direct |
3,199
+11.94%
|
-
|
|
Dec 08
2023
|
Daniel P Van Plew EVP & General Mgr Industrial O |
SELL
Payment of exercise price or tax liability
|
Direct |
1,108
-5.15%
|
$934,044
$843.79 P/Share
|
|
Dec 08
2023
|
Christopher R. Fenimore VP Controller |
BUY
Grant, award, or other acquisition
|
Direct |
2,370
+9.4%
|
-
|
|
Dec 08
2023
|
Christopher R. Fenimore VP Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
474
-2.26%
|
$399,582
$843.79 P/Share
|
|
Dec 08
2023
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,013
-3.2%
|
$853,959
$843.79 P/Share
|
|
Dec 08
2023
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Grant, award, or other acquisition
|
Direct |
2,133
+6.5%
|
-
|
|
Dec 08
2023
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
852
-2.9%
|
$718,236
$843.79 P/Share
|
|
Dec 08
2023
|
Marion Mc Court EVP Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
2,133
+9.19%
|
-
|
|
Dec 08
2023
|
Marion Mc Court EVP Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
852
-4.3%
|
$718,236
$843.79 P/Share
|
|
Dec 05
2023
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
6,536
-0.86%
|
$5,326,840
$816.0 P/Share
|
|
Dec 04
2023
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
13,464
-16.95%
|
$10,946,232
$813.58 P/Share
|
|
Dec 04
2023
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+20.12%
|
$5,400,000
$270.43 P/Share
|
|
Dec 01
2023
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$81,800
$818.55 P/Share
|
|
Nov 14
2023
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
6,492
-0.93%
|
$5,193,600
$800.35 P/Share
|
|
Nov 13
2023
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
13,508
-17.01%
|
$10,738,860
$795.69 P/Share
|
|
Nov 13
2023
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+20.12%
|
$5,400,000
$270.43 P/Share
|
|
Nov 10
2023
|
Neil Stahl EVP Research and Development |
SELL
Bona fide gift
|
Direct |
400
-0.75%
|
-
|
|
Nov 07
2023
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.07%
|
$82,800
$828.9 P/Share
|
|
Nov 01
2023
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-4.81%
|
$783,000
$783.91 P/Share
|
|
Nov 01
2023
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+4.59%
|
$381,000
$381.4 P/Share
|
|
Oct 13
2023
|
Huda Y Zoghbi Director |
SELL
Open market or private sale
|
Direct |
1,000
-44.5%
|
$850,000
$850.0 P/Share
|
|
Oct 13
2023
|
Huda Y Zoghbi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+30.8%
|
$391,000
$391.92 P/Share
|
|
Oct 02
2023
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,038
-4.98%
|
$858,426
$827.0 P/Share
|
|
Oct 02
2023
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,038
+4.74%
|
$386,136
$372.46 P/Share
|
|
Sep 08
2023
|
David P Schenkein Director |
BUY
Grant, award, or other acquisition
|
Direct |
240
+50.0%
|
-
|
|
Sep 08
2023
|
Kathryn Guarini Director |
BUY
Grant, award, or other acquisition
|
Direct |
240
+50.0%
|
-
|
|
Sep 01
2023
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
250
-1.25%
|
$208,500
$834.55 P/Share
|
|
Aug 24
2023
|
Daniel P Van Plew EVP & General Mgr Industrial O |
SELL
Open market or private sale
|
Direct |
6,197
-2.46%
|
$5,199,283
$839.93 P/Share
|
|
Aug 23
2023
|
Daniel P Van Plew EVP & General Mgr Industrial O |
SELL
Payment of exercise price or tax liability
|
Direct |
16,928
-37.93%
|
$14,253,376
$842.66 P/Share
|
|
Aug 23
2023
|
Daniel P Van Plew EVP & General Mgr Industrial O |
BUY
Exercise of conversion of derivative security
|
Direct |
23,125
+34.13%
|
$8,810,625
$381.4 P/Share
|
|
Aug 23
2023
|
Christine A Poon Director |
SELL
Open market or private sale
|
Direct |
12,280
-26.61%
|
$10,302,920
$839.53 P/Share
|
|
Aug 23
2023
|
Christine A Poon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,280
+46.17%
|
$3,352,440
$273.67 P/Share
|